by Webdesign Squad | Jul 6, 2026 | News, Press Release
Press Release Carvolix presents promising clinical data on the TAVIPILOT platform at New York Valves 2026 July 06, 2026 Read More...
by Webdesign Squad | Jun 24, 2026 | News, Press Release
Press Release Carvolix Secures New EUR 10m Tranche, Bringing Total Financing to EUR 20m as Part of its EUR 30m Programme June 24, 2026 Read More...
by Webdesign Squad | Jun 17, 2026 | News, Press Release
Press Release Carvolix announces positive 3-years clinical results for Kalios™, the only adjustable mitral ring June 16, 2026 Read More...
by Webdesign Squad | May 5, 2026 | News, Press Release
Press Release Carvolix Announces Positive Results of the Postmarketing Clinical Program Evaluating the TAVIPILOT AI Software May 4, 2026 Read More...
by wpAdm | Feb 14, 2026 | News, Press Release
Press Release Carvolix is born and funded Affluent Medical officially becomes CARVOLIX Completion of the acquisitions of CARANX MEDICAL and ARTEDRONE 10m€ first tranche of financing completed February 2026 Read More...
by wpAdm | Dec 12, 2025 | News, Press Release
Press Release Caranx Medical announces first clinical use of the TAVIPILOT Soft, cleared by FDA for commercial in July: the world first AI Software for real-time intra-operative guidance of transcatheter heart valve implantation. December 2025 Read More...
Recent Comments